← Back to home

Germany's Merck KGaA to Buy Silence Therapeutics for About $1.3 Billion, Adding Rare Blood Cancer Drug

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

Merck KGaA agreed Monday to buy Silence Therapeutics for about $1.3 billion in…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

4 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home